@dkotliar.bsky.social
Some highlights from the revision:
We applied starCAT to several cancer datasets and found that having more proliferating and activated CD4 and CD8 T cells in a tumor predicts immune checkpoint inhibitor resistance. starCAT made this very easy to test!
We applied starCAT to several cancer datasets and found that having more proliferating and activated CD4 and CD8 T cells in a tumor predicts immune checkpoint inhibitor resistance. starCAT made this very easy to test!
September 3, 2025 at 4:46 PM
Some highlights from the revision:
We applied starCAT to several cancer datasets and found that having more proliferating and activated CD4 and CD8 T cells in a tumor predicts immune checkpoint inhibitor resistance. starCAT made this very easy to test!
We applied starCAT to several cancer datasets and found that having more proliferating and activated CD4 and CD8 T cells in a tumor predicts immune checkpoint inhibitor resistance. starCAT made this very easy to test!